Concepedia

Mohammed Alnaggar

MA

Statistics

Publications

8

Citations

681

H-Index

8

Active since

2017

Affiliations

Jinan University(Current)

Fuda Cancer Hospital

Huazhong University of Science and Technology

Tongji Hospital

First Affiliated Hospital of Jinan University

Mohammed Alnaggar is an author at Jinan University specializing in oncology, immunology, and immunotherapy.

ORCID

Publications per year

2017–2021

8

Publications

8

Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer

Yan Xu, Zheng Xiang, Mohammed Alnaggar et al. · Cellular and Molecular Immunology · 2020 · 251 citations · Full text

, , +17

Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma

Mohammed Alnaggar, Yan Xu, Jingxia Li et al. · Journal for ImmunoTherapy of Cancer · 2019 · 128 citations · Full text

, , +14

Irreversible electroporation plus allogenic Vγ9Vδ2 T cells enhances antitumor effect for locally advanced pancreatic cancer patients

Mao Lin, Xiaoyan Zhang, Shuzhen Liang et al. · Signal Transduction and Targeted Therapy · 2020 · 91 citations · Full text

, , +17

Allogenic Natural Killer Cell Immunotherapy Combined with Irreversible Electroporation for Stage IV Hepatocellular Carcinoma: Survival Outcome

Mohammed Alnaggar, Mao Lin, Adnan Mesmar et al. · Cellular Physiology and Biochemistry · 2018 · 68 citations · Full text

, , +16

Silver nanoparticles induce cell death of colon cancer cells through impairing cytoskeleton and membrane nanostructure

Hefang Xiao, Yan Chen, Mohammed Alnaggar · Micron · 2019 · 49 citations

, , +16

1–5 of 8